Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets Medical Dialogues Bureau10 April 2020 7:30 AM GMTHyderabad: Aurobindo Pharma Limited has announced that the Company has received the final approval from the US Food & Drug Administration (USFDA) t...
Aurobindo Pharma faces CA Suit in US for concealing facts Medical Dialogues Bureau9 April 2020 8:06 AM GMTHyderabad: A class-action suit has been filed against some drug manufacturers, including Aurobindo Pharma and Emcure Pharmaceuticals, in a USA court fo...
Aurobindo, Sandoz call off 900 million US dollar deal Medical Dialogues Bureau2 April 2020 9:57 AM GMTNew Delhi: Aurobindo Pharma on Thursday said the USD 900 million deal to acquire Sandoz Inc''s US-based generic oral solids and dermatology businesses,...
NPPA directs 3 pharma cos to maintain stock of atleast 2.2 crore tablets of FDC Lopinavir and Ritoavir Medical Dialogues Bureau29 March 2020 7:49 AM GMTNew Delhi: The National Pharmaceuticals Pricing Authority (NPPA), Department of Pharmaceuticals directed 3 major manufacturers of the HIV Combo...